1. Contractors
  2. Amgen USA Inc

Amgen USA Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Amgen USA has 3 federal contracts of $100,000 or more active since October 2023, with $841M obligated, from 1 agency. 1 is still running.

Contracts
3 since FY2024$841,344,520 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Office of Assistant Secretary for Preparedness and Response$841M on 3 contracts
UEI
XPGNQMXHP493Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2022$839,875,190
FY2024$811,924

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Treatment for Use in a Mass Casualty Event Where Thrombocytopenia or Platelet Loss Is a Major Concern.Office of Assistant Secretary for Preparedness and Response · 75A50122C00065$839,875,190Sep 29, 2032in 70 monthsCA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount, $M
Office of Assistant Secretary for Preparedness and Response3 contracts841.3

What they sell

IndustryAmount, $M
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts840.7
Biological Product (except Diagnostic) ManufacturingNAICS 325414 · 1 contract0.7

Where the work is

Place of workAmount, $M
California3 contracts841.3

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Amgen USA's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy